Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 278

1.

The role of inflammation in Alzheimer's disease.

Tuppo EE, Arias HR.

Int J Biochem Cell Biol. 2005 Feb;37(2):289-305. Review.

PMID:
15474976
[PubMed - indexed for MEDLINE]
2.

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

Halliday G, Robinson SR, Shepherd C, Kril J.

Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.

PMID:
10696521
[PubMed - indexed for MEDLINE]
3.

Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.

Sastre M, Klockgether T, Heneka MT.

Int J Dev Neurosci. 2006 Apr-May;24(2-3):167-76. Epub 2006 Feb 10. Review.

PMID:
16472958
[PubMed - indexed for MEDLINE]
4.

Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.

Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M.

J Neuropathol Exp Neurol. 2007 Jun;66(6):469-80.

PMID:
17549007
[PubMed - indexed for MEDLINE]
5.

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.

Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B.

Aging Cell. 2004 Aug;3(4):169-76. Review.

PMID:
15268750
[PubMed - indexed for MEDLINE]
6.

Inflammatory processes in Alzheimer's disease.

McGeer EG, McGeer PL.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):741-9. Review.

PMID:
12921904
[PubMed - indexed for MEDLINE]
7.

MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.

Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, Richardson JC.

J Biol Chem. 2006 Aug 18;281(33):23658-67. Epub 2006 Jun 14.

PMID:
16774924
[PubMed - indexed for MEDLINE]
Free Article
8.

Neuroinflammation in Alzheimer's disease: protector or promoter?

Zilka N, Ferencik M, Hulin I.

Bratisl Lek Listy. 2006;107(9-10):374-83. Review.

PMID:
17262990
[PubMed - indexed for MEDLINE]
9.

Inflammation and Alzheimer's disease.

Lee YJ, Han SB, Nam SY, Oh KW, Hong JT.

Arch Pharm Res. 2010 Oct;33(10):1539-56. doi: 10.1007/s12272-010-1006-7. Epub 2010 Oct 30. Review.

PMID:
21052932
[PubMed - indexed for MEDLINE]
10.

A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Ryu JK, McLarnon JG.

J Cell Mol Med. 2009 Sep;13(9A):2911-25. doi: 10.1111/j.1582-4934.2008.00434.x. Epub 2008 Jul 24.

PMID:
18657226
[PubMed - indexed for MEDLINE]
11.

Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.

Bamberger ME, Landreth GE.

Microsc Res Tech. 2001 Jul 15;54(2):59-70. Review.

PMID:
11455613
[PubMed - indexed for MEDLINE]
12.

Microglial activation in Alzheimer's disease.

Schlachetzki JC, Hüll M.

Curr Alzheimer Res. 2009 Dec;6(6):554-63. Review.

PMID:
19747160
[PubMed - indexed for MEDLINE]
13.

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.

Potter H, Wefes IM, Nilsson LN.

Neurobiol Aging. 2001 Nov-Dec;22(6):923-30. Review.

PMID:
11755000
[PubMed - indexed for MEDLINE]
14.

Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease.

Popović M, Caballero-Bleda M, Puelles L, Popović N.

Int J Neurosci. 1998 Sep;95(3-4):203-36. Review.

PMID:
9777440
[PubMed - indexed for MEDLINE]
15.

Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.

Agostinho P, Cunha RA, Oliveira C.

Curr Pharm Des. 2010;16(25):2766-78. Review.

PMID:
20698820
[PubMed - indexed for MEDLINE]
16.

Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.

Farfara D, Lifshitz V, Frenkel D.

J Cell Mol Med. 2008 Jun;12(3):762-80. doi: 10.1111/j.1582-4934.2008.00314.x. Epub 2008 Mar 20. Review.

PMID:
18363841
[PubMed - indexed for MEDLINE]
17.

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A.

Int Rev Neurobiol. 2007;82:235-46. Review.

PMID:
17678964
[PubMed - indexed for MEDLINE]
18.

Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.

van Groen T, Kadish I.

Brain Res Brain Res Rev. 2005 Apr;48(2):370-8.

PMID:
15850676
[PubMed - indexed for MEDLINE]
19.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
[PubMed - indexed for MEDLINE]
20.

Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years.

McGeer PL, Rogers J, McGeer EG.

J Alzheimers Dis. 2006;9(3 Suppl):271-6. Review.

PMID:
16914866
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk